Expression analysis in a rat psychosis model identifies novel candidate genes validated in a large case–control sample of schizophrenia
Citations Over TimeTop 10% of 2015 papers
Abstract
Antagonists of the N-methyl-D-aspartate (NMDA)-type glutamate receptor induce psychosis in healthy individuals and exacerbate schizophrenia symptoms in patients. In this study we have produced an animal model of NMDA receptor hypofunction by chronically treating rats with low doses of the NMDA receptor antagonist MK-801. Subsequently, we performed an expression study and identified 20 genes showing altered expression in the brain of these rats compared with untreated animals. We then explored whether the human orthologs of these genes are associated with schizophrenia in the largest schizophrenia genome-wide association study published to date, and found evidence for association for 4 out of the 20 genes: SF3B1, FOXP1, DLG2 and VGLL4. Interestingly, three of these genes, FOXP1, SF3B1 and DLG2, have previously been implicated in neurodevelopmental disorders.
Related Papers
- → σ-Ligands and non-competitive NMDA antagonists inhibit glutamate release during cerebral ischemia(1990)95 cited
- → Ethanol inhibits NMDA‐induced toxicity and trophism in cultured cerebellar granule cells(1995)25 cited
- → Age-related effects of NMDA-stimulated concomitant release of nitric oxide and glutamate in cortical slices prepared from DBA/2 mice(1993)14 cited
- → Book Review: Implementing Early Intervention in Psychosis: A Guide to Establishing Early Psychosis Services(2004)
- → 32.4 EARLY TREATMENT ENGAGEMENT AMONG TRANSITION-AGE YOUTH WITH PSYCHOSIS: FINDINGS FROM AN EARLY PSYCHOSIS INTERVENTION PROGRAM(2020)